Menten AI
Menten AI designs peptide therapeutics that address targets beyond the reach of small molecules and biologics. The company uses a proprietary platform (MAUD 1.0) that combines generative AI, machine learning, physics-based methods, and quantum computing to generate and evaluate peptide macrocycles with drug-like properties. Menten focuses on cyclic peptides and macrocycles to improve oral bioavailability and cell permeability for challenging targets. The platform has demonstrated large increases in sampling power and a high hit rate across validated targets, including an anti-viral peptide, and is applied in partnerships with pharmaceutical and biotech developers.
Menten AI
Menten AI designs peptide therapeutics that address targets beyond the reach of small molecules and biologics. The company uses a proprietary platform (MAUD 1.0) that combines generative AI, machine learning, physics-based methods, and quantum computing to generate and evaluate peptide macrocycles with drug-like properties. Menten focuses on cyclic peptides and macrocycles to improve oral bioavailability and cell permeability for challenging targets. The platform has demonstrated large increases in sampling power and a high hit rate across validated targets, including an anti-viral peptide, and is applied in partnerships with pharmaceutical and biotech developers.